ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000

NCI Drops Protocol Review Requirement To Encourage firs To List Trials On PDQ

October 24, 1997

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

NCI Sends A Second Letter To Groups About Carboplatin

October 22, 2010